Sanofi Multiple Sclerosis Drug Gets EU Approval

2 weeks ago 24
The authorization of Cenrifki for the attraction of secondary progressive aggregate sclerosis without relapses follows a rejection from U.S. cause regulators.
Read Entire Article
  1. Homepage
  2. Health
  3. Sanofi Multiple Sclerosis Drug Gets EU Approval

Related

GLP-1s changed one woman’s battle with bulimia, we put fitness trackers to the test, and panic pouches are on the rise. Read more in this week’s Health newsletter:

GLP-1s changed one woman’s battle with bulimia, we put fitne...

5 hours ago 2
Pioneering treatment saves twins in early pregnancy

Pioneering treatment saves twins in early pregnancy

6 hours ago 1
More Americans are testing positive for marijuana in workplace drug tests, raising questions among employers over their usefulness in screening job candidates

More Americans are testing positive for marijuana in workpla...

9 hours ago 1

Popular

A walk through Taylor Swift’s New York on her wedding day.

A walk through Taylor Swift’s New York on her wedding day.

6 days ago 15
Turbines turning from wind to sustainable products

Turbines turning from wind to sustainable products

6 days ago 15
As dementia complicates caregiving, families confront a painful question: Is deception ever the kinder choice?

As dementia complicates caregiving, families confront a pain...

6 days ago 15
President Trump spoke in front of Mount Rushmore ahead of the country’s Independence Day celebration, at the memorial honoring four past presidents that he has mused about joining

President Trump spoke in front of Mount Rushmore ahead of th...

6 days ago 14
Scientist dubbed The Bogfather is restoring peatland to fight climate change

Scientist dubbed The Bogfather is restoring peatland to figh...

6 days ago 14
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved